Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcus Biosciences, Inc. Director's Dealing 2020

Jul 13, 2020

31966_dirs_2020-07-13_e53b0b9a-6e3b-4774-a170-4b712173eef1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2020-07-13

Reporting Person: Parsey Merdad (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Direct